Showing results (1161-1170 of 1,351) with videos related to
Sort By:
Pageof 136
European Journal of Cancer (Oxford, England : 1990)|July 24, 2023
Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) studyGeorg C Lodde, Jessica Hassel, Lena M Wulfken, et al.European Journal of Cancer (Oxford, England : 1990)|July 10, 2019
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelinesKetty Peris, Maria Concetta Fargnoli, Claus Garbe, et al.European Journal of Cancer (Oxford, England : 1990)|April 18, 2018
Advanced cutaneous squamous cell carcinoma: A retrospective analysis of patient profiles and treatment patterns-Results of a non-interventional study of the DeCOGUwe Hillen, Ulrike Leiter, Sylvie Haase, et al.European Journal of Cancer (Oxford, England : 1990)|January 24, 2018
Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective studySara Valpione, Matteo S Carlino, Johanna Mangana, et al.The Lancet. Oncology|February 16, 2026
Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-IV melanoma (KEYVIBE-010): a randomised, double-blind, phase 3 studyReinhard Dummer, Jun Guo, Jason J Luke, et al.Molecular Pharmaceutics|September 21, 2023
Rhizochalinin Exhibits Anticancer Activity and Synergizes with EGFR Inhibitors in Glioblastoma In Vitro ModelsSergey A Dyshlovoy, Jessica Hauschild, Simone Venz, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 14, 2014
Congenital hypogonadotropic hypogonadism with split hand/foot malformation: a clinical entity with a high frequency of FGFR1 mutationsCarine Villanueva, Elka Jacobson-Dickman, Cheng Xu, et al.Physical Review Letters|December 31, 2005
Excitation energies of superdeformed States in 196Pb: towards a systematic study of the second well in Pb isotopesA N Wilson, A K Singh, H Hübel, et al.Oncotarget|September 15, 2016
Marine compound rhizochalinin shows high in vitro and in vivo efficacy in castration resistant prostate cancerSergey A Dyshlovoy, Katharina Otte, Winfried H Alsdorf, et al.The New England Journal of Medicine|June 6, 2019
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic MelanomaCaroline Robert, Jean J Grob, Daniil Stroyakovskiy, et al.Pageof 136